GFA
AZN icon

Godfrey Financial Associates’s AstraZeneca AZN Stock Holding History

Godfrey Financial Associates’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$948 Sell
5
-1
-17% -$188 ﹤0.01% 800
2026
Q1 		$1.18K Sell
6
-1
-14% -$193 ﹤0.01% 748
2025
Q4 		$14 Buy
+7
New +$1.23K ﹤0.01% 1103

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Godfrey Financial Associates's AZN Position: Q2 2026 in Review

Godfrey Financial Associates reduced its AstraZeneca (AZN) stake by 17% in Q2 2026, selling an estimated $188 and leaving 5 shares worth $948. The position accounts for ﹤0.01% of the portfolio, ranked #800.

Godfrey Financial Associates first reported a position in AZN in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.18K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Godfrey Financial Associates held 5 shares of AstraZeneca worth $948 as of Q2 2026.
  • Godfrey Financial Associates sold 1 AstraZeneca share in Q2 2026, an estimated $188.
  • AstraZeneca made up ﹤0.01% of Godfrey Financial Associates's portfolio in Q2 2026, its #800 holding.
  • Godfrey Financial Associates first reported a position in AstraZeneca in Q4 2025 and has held it in 3 quarters since.
  • Godfrey Financial Associates's AstraZeneca position peaked at $1.18K in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Godfrey Financial Associates's 13F filing for Q2 2026, filed 11 Aug 2026.